• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

工程化肾组织作为药代动力学和肾毒性测试的潜在平台。

Engineered renal tissue as a potential platform for pharmacokinetic and nephrotoxicity testing.

作者信息

Davies Jamie

机构信息

University of Edinburgh, United Kingdom.

出版信息

Drug Discov Today. 2014 Jun;19(6):725-9. doi: 10.1016/j.drudis.2013.10.023. Epub 2013 Nov 4.

DOI:10.1016/j.drudis.2013.10.023
PMID:24201224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7615218/
Abstract

Pharmacology and regenerative medicine interact in two ways. One is the use of drugs to promote tissue regeneration. The other, less obvious but with great potential, is the use of techniques developed for regenerative medicine to engineer realistic human organoids for drug screening. This review focuses on testing for nephrotoxicity, often a problem with drugs and poorly predicted in animals. Current human-based screens mainly use proximal tubule cells growing in 2D monolayers. Realism might be improved by collagen-based culture systems that encourage proximal tubule cells to grow as tubules. More realistic would be a recently developed technique for engineering functioning 'mini-kidneys' from suspensions of stem cells, a technique that works in mouse but that could also be applied to humans.

摘要

药理学与再生医学以两种方式相互作用。一种是使用药物促进组织再生。另一种方式不太明显但潜力巨大，即利用再生医学所开发的技术构建逼真的人体类器官用于药物筛选。本综述聚焦于肾毒性测试，肾毒性常常是药物存在的一个问题，且在动物实验中难以准确预测。当前基于人体的筛选主要使用在二维单层培养的近端小管细胞。基于胶原蛋白的培养系统或许能提高真实性，该系统可促使近端小管细胞生长为小管。更逼真的是一项最近开发的技术，即利用干细胞悬液构建具有功能的“微型肾脏”，该技术已在小鼠实验中成功应用，也有望应用于人类。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9fb/7615218/6189e8a7336e/EMS189491-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9fb/7615218/2cc0b80cbcad/EMS189491-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9fb/7615218/6189e8a7336e/EMS189491-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9fb/7615218/2cc0b80cbcad/EMS189491-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9fb/7615218/6189e8a7336e/EMS189491-f002.jpg

相似文献

1
Engineered renal tissue as a potential platform for pharmacokinetic and nephrotoxicity testing.工程化肾组织作为药代动力学和肾毒性测试的潜在平台。
Drug Discov Today. 2014 Jun;19(6):725-9. doi: 10.1016/j.drudis.2013.10.023. Epub 2013 Nov 4.
2
Generation of easily accessible human kidney tubules on two-dimensional surfaces in vitro.在体外二维表面上生成易于接近的人类肾小管。
J Cell Mol Med. 2011 Jun;15(6):1287-98. doi: 10.1111/j.1582-4934.2010.01113.x. Epub 2010 Jun 25.
3
A murine ex vivo 3D kidney proximal tubule model predicts clinical drug-induced nephrotoxicity.一种基于鼠类的体外 3D 肾脏近端小管模型可预测临床药物诱导的肾毒性。
Arch Toxicol. 2019 May;93(5):1349-1364. doi: 10.1007/s00204-019-02430-9. Epub 2019 Mar 12.
4
Drug transporter expression profiling in a three-dimensional kidney proximal tubule in vitro nephrotoxicity model.在三维肾脏近端肾小管体外肾毒性模型中药物转运体的表达谱分析。
Pflugers Arch. 2018 Sep;470(9):1311-1323. doi: 10.1007/s00424-018-2150-z. Epub 2018 May 9.
5
Relationship of MATE1 Inhibition and Cytotoxicity in Nephrotoxicity: Application for Safety Evaluation in Early Drug Discovery.MATE1 抑制与肾毒性细胞毒性的关系：在早期药物发现中的安全性评估应用。
Toxicol Sci. 2019 Jul 1;170(1):223-233. doi: 10.1093/toxsci/kfz093.
6
Generation of Functional Kidney Organoids In Vivo Starting from a Single-Cell Suspension.从单细胞悬液开始在体内生成功能性肾类器官。
Methods Mol Biol. 2019;1576:101-112. doi: 10.1007/7651_2016_2.
7
Tissue Culture Models of AKI: From Tubule Cells to Human Kidney Organoids.急性肾损伤的组织培养模型：从肾小管细胞到人类肾类器官。
J Am Soc Nephrol. 2022 Mar;33(3):487-501. doi: 10.1681/ASN.2021050693. Epub 2022 Jan 14.
8
Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells.利用胚胎干细胞来源的人肾近端小管样细胞鉴定肾毒性化合物。
Mol Pharm. 2014 Jul 7;11(7):1982-90. doi: 10.1021/mp400637s. Epub 2014 Feb 20.
9
Generation of tubular superstructures by piling of renal stem/progenitor cells.通过肾干细胞/祖细胞堆积生成管状超结构。
Tissue Eng Part C Methods. 2008 Mar;14(1):3-13. doi: 10.1089/tec.2007.0230.
10
Tissue-engineered kidney disease models.组织工程化肾脏疾病模型
Adv Drug Deliv Rev. 2014 Apr;69-70:67-80. doi: 10.1016/j.addr.2013.12.002. Epub 2013 Dec 17.

引用本文的文献

1
A Novel Protocol for Culturing Polarized Proximal Tubular Epithelial Cells from Kidney Biopsies: Enhancing Platforms for Drug Excretion and Nephrotoxicity Studies.一种从肾活检组织中培养极化近端肾小管上皮细胞的新方案：增强药物排泄和肾毒性研究的平台
J Xenobiot. 2025 Apr 1;15(2):52. doi: 10.3390/jox15020052.
2
Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models.在体外细胞模型中，盐皮质激素受体拮抗剂的临床特性和非临床测试。
Int J Mol Sci. 2024 Aug 22;25(16):9088. doi: 10.3390/ijms25169088.
3
Scientific Advances in Diabetes: The Impact of the Innovative Medicines Initiative.糖尿病领域的科学进展：创新药物倡议的影响
Front Med (Lausanne). 2021 Jul 6;8:688438. doi: 10.3389/fmed.2021.688438. eCollection 2021.
4
Formation and optimization of three-dimensional organoids generated from urine-derived stem cells for renal function in vitro.基于尿液来源干细胞的三维类器官的形成和优化及其在体外的肾功能研究。
Stem Cell Res Ther. 2020 Jul 22;11(1):309. doi: 10.1186/s13287-020-01822-4.
5
Review of high-content screening applications in toxicology.毒理学中高通量筛选应用的回顾。
Arch Toxicol. 2019 Dec;93(12):3387-3396. doi: 10.1007/s00204-019-02593-5. Epub 2019 Oct 29.
6
Asymmetric BMP4 signalling improves the realism of kidney organoids.不对称的 BMP4 信号可提高肾类器官的真实性。
Sci Rep. 2017 Nov 1;7(1):14824. doi: 10.1038/s41598-017-14809-8.
7
Directed differentiation of pluripotent stem cells to kidney cells.多能干细胞向肾细胞的定向分化。
Semin Nephrol. 2014 Jul;34(4):445-61. doi: 10.1016/j.semnephrol.2014.06.011. Epub 2014 Jun 13.

本文引用的文献

1
Engineering kidneys from simple cell suspensions: an exercise in self-organization.从简单细胞悬液构建肾脏：一项关于自我组织的实验。
Pediatr Nephrol. 2014 Apr;29(4):519-24. doi: 10.1007/s00467-013-2579-4. Epub 2013 Aug 30.
2
3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies.3D 器官型 HepaRG 培养物作为急性和重复剂量毒性研究的体外模型。
Toxicol In Vitro. 2014 Feb;28(1):104-12. doi: 10.1016/j.tiv.2013.06.024. Epub 2013 Jul 9.
3
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment.人肾近端小管芯片用于药物转运和肾毒性评估。
Integr Biol (Camb). 2013 Sep;5(9):1119-29. doi: 10.1039/c3ib40049b.
4
Hospital-acquired acute kidney injury in medical, surgical, and intensive care unit: A comparative study.内科、外科及重症监护病房医院获得性急性肾损伤：一项对比研究。
Indian J Nephrol. 2013 Jan;23(1):24-9. doi: 10.4103/0971-4065.107192.
5
Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients.Dent 病患者的近端肾小管上皮细胞存在受体介导的内吞作用和内体酸化受损。
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):7014-9. doi: 10.1073/pnas.1302063110. Epub 2013 Apr 9.
6
Human embryonic stem cells differentiate into functional renal proximal tubular-like cells.人类胚胎干细胞分化为具有功能的肾近端管状样细胞。
Kidney Int. 2013 Apr;83(4):593-603. doi: 10.1038/ki.2012.442. Epub 2013 Feb 6.
7
Systematic reviews of animal models: methodology versus epistemology.系统评价动物模型：方法学与认识论。
Int J Med Sci. 2013;10(3):206-21. doi: 10.7150/ijms.5529. Epub 2013 Jan 11.
8
Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells.从人类多能干细胞中监测和稳健诱导肾原中胚层。
Nat Commun. 2013;4:1367. doi: 10.1038/ncomms2378.
9
An improved method of renal tissue engineering, by combining renal dissociation and reaggregation with a low-volume culture technique, results in development of engineered kidneys complete with loops of Henle.通过将肾组织分离和再聚集与小体积培养技术相结合，改进了肾脏组织工程方法，可构建具有 Henle 袢的工程化肾脏。
Nephron Exp Nephrol. 2012;121(3-4):e79-85. doi: 10.1159/000345514. Epub 2012 Dec 7.
10
In vivo maturation of functional renal organoids formed from embryonic cell suspensions.胚胎细胞悬液体外诱导形成功能性肾类器官。
J Am Soc Nephrol. 2012 Nov;23(11):1857-68. doi: 10.1681/ASN.2012050505. Epub 2012 Oct 18.